drugset / Trial / NCT00347672

Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

NCT00347672 ↗

RandomizedParallel-groupOpen-labelPrevention

Summary

Avian influenza (AI), or bird flu, has recently become a major health concern in Asia and other parts of the world. The need for a vaccine to prevent the spread of AI among livestock and to humans is sorely needed. The purpose of this study is to test the safety of and immune response to a new AI vaccine in healthy adults.

Timeline

Start
2006-06
Primary completion
2007-07
Completion
2007-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject H5N1 (6-2) AA ca Recombinant (A/VietNam/1203/2004 x A/AnnArbor/6/60/ca) Unknown 5.01187e+06 unknown Intranasal
Subject H5N1 (6-2) AA ca Recombinant (A/VietNam/1203/2004 x A/AnnArbor/6/60/ca) Unknown 3.16228e+07 unknown Intranasal

Indications